As glucose metabolism can regulate the expression of EGFR, and the mutation and expression of EGFR can regulate the expression of PD-L132, we hypothesised that PD-L1 expression is regulated by activating EGFR in the context of glucose deficiency in renal cancer cells. Here, EGFR is linked to renal carcinoma.